Conference Coverage EHA 2023 – Focus on Multiple Myeloma (US)

The latest therapeutic developments in multiple myeloma – how will they change our approach to treatment patterns?

June 10, 2023

Faculty Chair

Rafael Fonseca, MD

Mayo Clinic, Phoenix, AZ, USA

Faculty Members

Ajai Chari, MD
Mount Sinai, New York, NY, USA

Krina K. Patel, MD
MD Anderson Cancer Center, Houston, TX, USA

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA, USA

Luciano J. Costa, MD, PhD
University of Alabama at Birmingham, Birmingham, AL, USA

Amrita Krishnan, MD
City of Hope Comprehensive Cancer Center, Duarte, CA, USA


Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • Treatment in Transplant-Eligible and Smoldering Multiple Myeloma
  • NDMM: Transplant-Ineligible Multiple Myeloma
  • Relapsed/Refractory Multiple Myeloma: Small Molecules
  • Relapsed/Refractory Multiple Myeloma: Antibodies and Bispecifics
  • Relapsed/Refractory Multiple Myeloma: CAR T

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.